Curative Ventures

GIF89a;

Priv8 Uploader By InMyMine7

Linux prod-iad-vuxweb1501ao 5.14.0-687.26.1.el9_8.x86_64 #1 SMP PREEMPT_DYNAMIC Tue Jul 14 16:32:02 EDT 2026 x86_64
Curative Ventures

Loading...

HomeCurative Ventures2026-05-12T13:11:26-05:00

Curative Ventures is a capital and talent partner to category-defining biotech companies that are developing new therapies to dramatically improve patient outcomes.

Recent Investments

InstilBioCurative Ventures2021-02-25T15:52:17-06:00

InstilBio

CoStimCurative Ventures2019-03-07T03:55:55-06:00

https://www.novartis.com/

iTeos TherapeuticsCurative Ventures2018-06-20T09:55:53-05:00

http://www.iteostherapeutics.com/

TCR2Curative Ventures2018-03-20T09:08:29-05:00

http://www.tcr2.com/

Peloton TherapeuticsCurative Ventures2019-03-07T09:02:27-06:00

https://www.pelotontherapeutics.com/

Press Releases

Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody

DALLAS and SHANGHAI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Instil [...]

August 1st, 2024|

Instil Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

DALLAS, March 23, 2021 (GLOBE NEWSWIRE) -- Instil Bio, Inc. [...]

March 23rd, 2021|

Vertex Enters Duchenne Therapy Market with $1B Acquisition of Exonics

Move over, Sarepta Therapeutics, Solid Biosciences, PTC Therapeutics and [...]

August 26th, 2019|

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline Acquisition [...]

May 12th, 2019|

Peloton Therapeutics Secures $150 Million in Series E Financing

- Proceeds to advance oral HIF-2α inhibitor, PT2977, into [...]

February 14th, 2019|

TCR2 Therapeutics Prices IPO Of 5 Mln Shares At $15.00/shr

(RTTNews) Feb 13, 2019 - TCR2 Therapeutics Inc. (TCRR) said [...]

February 13th, 2019|

Contact Us

Curative Ventures
info@curativeventures.com

Address
3963 Maple Avenue, Suite 350
Dallas, TX 75219